Comparison of Adiponectin Level in Women with Breast Cancer with Healthy Women

Fatemeh Homaee, Kamran Ghaffarzadehgan, Azar Aziminia, Hamideh Ghodrati, Azra Izanloo, Reza ziaolhagh, Sahar Ardalan Khales

Abstract


Introduction: Adiponectin is one of the plasma protein derived from adipose tissue which has a positive effect on metabolism of fat and lipid, resulting from its own receptors.

Increase in body mass index (BMI) has a direct relationship with life length. Obesity has effects on secretion of some hormons related to adipokines. Adiponectin is an adipokine having an opposite relationship with insulin resistance and breast cancer. It is also the connection between breast cancer incidence and obesity. Adiponectin level decreases in women affected by breast cancer and knowing this fact can help treat and prevent the cancer by giving adiponectin supplements. The present study compared the adiponectin levels in women affected by breast cancer and healthy females as control group

Method: in this study, 80 women with breast cancer and 80 healthy females as controls were selected and adiponectin level was compared between them.

Result: the group with breast cancer, having a higher BMI mean (28.77 ± 6.05), showed a lower adiponectin level in comparison to control group .(p= 0.0001)

Conclusion: Considering the fact that the risk is higher in women with bigger BMI value, informing women in this regard could have a great effect on preventing this wide-spread disease. Taking adiponectin supplements as pills or injection could be a preventing step for breast cancer, which needs to be considered as targets for future studies.


Full Text:

PDF (FULL TEXT)

References


- Arditi JD, Venihaki M, Karalis KP, Chrousos GP. (2007). Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res, 39, 9-13.

- Carmichael AR, Bates T. (2004). Obesity and breast cancer: a review of the literature. Breast, 13, 85–92.

- Chen D.C., Chung Y. F., Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY.et al. (2006). Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett, 237, 109-14

- Chandran, M., S. A. Phillips, et al. (2003). Adiponectin: more than just another fat cell hormone?. Diabetes care, 26, 2442-2450.

- Dalamaga M, Diakopoulos KN, Mantzoros CS. (2012). the role of adiponectin in cancer: a review of current evidence. Endocrine reviews, 33, 547-594.

- Grossmann M, Nkhata K, Mizuno N, Ray A, Cleary M. (2008). Effects of adiponectin on breast cancer cell growth and signaling. British journal of cancer, 98, 370-9.

- Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250, 1684-9.

- Kadowaki, T, Yamauchi T. (2005). Adiponectin and adiponectin receptors. Endocrine reviews, 26, 439-451.

- Kang J. H.,. Yu B.Y, Youn D.S. (2007). Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci, 22, 117–121.

- Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, et al. (2009). Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clinical Cancer Research, 15, 3265-3276.

- Liu L-Y, Wang M, Ma Z-B, Yu L-X, Zhang Q, Gao D-Z, et al. (2013). The role of adiponectin in breast cancer: a meta-analysis. PLoS One, 8, e73183.

- Macis D, Guerrieri-Gonzaga A, et al. (2014). Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol, 43, 1226-36.

- Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, et al. (2004). Adiponectin and breast cancer risk. The Journal of Clinical Endocrinology & Metabolism, 89, 1102-7

- Meilian L, Feng L. (2014). Regulation of Adiponectin Multimerization, Signaling and Function. Best Pract Res Clin Endocrinol Metab, 28, 25–31.

- Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP activated protein kinase and Akt sign. J Biol Chem, 279, 1304-9.

- Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, et al. (2000). Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord, 24, 861–868

- Trujillo M.E, Scherer P.E. (2005).Adiponectin—journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med, 257, 167–175.

- Vayghan, H. J., Esfanjani A.T, Ebrahimi Mameghani1 M, Asghari Jafarabadi M, Ghadimi S, Lalezadeh Z. (2013). Sex Differences in Serum Leptin and Adiponectin levels in Apparently Healthy Iranian Adults. International Research Journal of Applied and Basic Sciences, 4, 3099-3103.

- Vrieling A, Buck K,Kaaks R,Chang-Claude J. (2010). Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status:a meta-analysis. BreastCancer Res Treat, 123, 641–649


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Asian Pacific Journal of Cancer Biology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 

  

PORTICO

 

Asia Pacific Organization for Cancer Prevention 

West Asia Organization for Cancer Prevention